Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dolby Laboratories (DLB) EBITDA Margin (2016 - 2025)

Dolby Laboratories (DLB) has disclosed EBITDA Margin for 17 consecutive years, with 17.93% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 445.0% year-over-year to 17.93%, compared with a TTM value of 18.47% through Dec 2025, down 221.0%, and an annual FY2025 reading of 19.64%, down 64.0% over the prior year.
  • EBITDA Margin was 17.93% for Q4 2025 at Dolby Laboratories, up from 9.67% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 29.89% in Q1 2024 and bottomed at 1.2% in Q3 2023.
  • Average EBITDA Margin over 5 years is 17.91%, with a median of 16.83% recorded in 2022.
  • The sharpest move saw EBITDA Margin plummeted -1650bps in 2021, then surged 1641bps in 2024.
  • Year by year, EBITDA Margin stood at 25.76% in 2021, then rose by 9bps to 28.09% in 2022, then fell by -25bps to 20.98% in 2023, then grew by 7bps to 22.38% in 2024, then dropped by -20bps to 17.93% in 2025.
  • Business Quant data shows EBITDA Margin for DLB at 17.93% in Q4 2025, 9.67% in Q3 2025, and 15.1% in Q2 2025.